These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34416247)

  • 1. Post-translational modifications talk and crosstalk to class IIa histone deacetylases.
    Guttzeit S; Backs J
    J Mol Cell Cardiol; 2022 Jan; 162():53-61. PubMed ID: 34416247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
    Eom GH; Kook H
    Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.
    Weeks KL; Avkiran M
    J Physiol; 2015 Apr; 593(8):1785-97. PubMed ID: 25362149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in class IIa histone deacetylases research.
    Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
    Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.
    Wright LH; Menick DR
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H199-206. PubMed ID: 27208161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease.
    Mathias RA; Guise AJ; Cristea IM
    Mol Cell Proteomics; 2015 Mar; 14(3):456-70. PubMed ID: 25616866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart.
    Habibian J; Ferguson BS
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
    Wang Z; Zhao YT; Zhao TC
    Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
    Bai G; Wei D; Zou S; Ren K; Dubner R
    Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
    Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
    Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation.
    Zhang D; Hu X; Henning RH; Brundel BJ
    Cardiovasc Res; 2016 Apr; 109(4):519-26. PubMed ID: 26645980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
    Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy.
    Patra S; Panigrahi DP; Praharaj PP; Bhol CS; Mahapatra KK; Mishra SR; Behera BP; Jena M; Bhutia SK
    Cell Mol Life Sci; 2019 Sep; 76(17):3263-3282. PubMed ID: 30982077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.
    Bouyahya A; El Hachlafi N; Aanniz T; Bourais I; Mechchate H; Benali T; Shariati MA; Burkov P; Lorenzo JM; Wilairatana P; Mubarak MS; El Omari N
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of class IIa HDAC activities: it is not only matter of subcellular localization.
    Di Giorgio E; Brancolini C
    Epigenomics; 2016 Feb; 8(2):251-69. PubMed ID: 26791815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
    Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
    J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.